(Q34497273)

2 August 2017

Dose-effect comparisons of the CINOD AZD3582 and naproxen on upper gastrointestinal tract mucosal injury in healthy subjects (English)

1 reference

2 August 2017

1 reference

Clive H Wilder-Smith

1

1 reference

2 August 2017

Bror Jonzon

2

1 reference

2 August 2017

Bodil Fornstedt-Wallin

3

1 reference

2 August 2017

Ann Hedman

4

1 reference

2 August 2017

Pär Karlsson

5

1 reference

2 August 2017

1 March 2006

1 reference

Scandinavian Journal of Gastroenterology

2 August 2017

1 reference

2 August 2017

41

1 reference

2 August 2017

3

1 reference

2 August 2017

264-273

1 reference

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

2 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Clinical economics review: gastrointestinal complications of non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Balancing gastroprotection and cardioprotection with selective cyclo-oxygenase-2 inhibitors: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract. Mechanisms of protection and healing: current knowledge and future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365520510024197

10.1080/00365520510024197

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference